FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4307989369> ?p ?o ?g. }

• W4307989369 endingPage "1794" @default.
• W4307989369 startingPage "1794" @default.
• W4307989369 abstract "The predictive factors of long-term clinical benefits in patients with hepatitis C virus (HCV)—related liver cirrhosis after Direct Antiviral Agents (DAA) treatment are still undefined. The aim of this study was to identify any predictors of liver failure, hepatocellular carcinoma (HCC) and/or death in patients with compensated liver cirrhosis who achieved the sustained virological response (SVR). To this purpose, 324 consecutive cirrhotic patients who started DAA treatment from 1 April 2015 to 31 December 2016 were retrospectively analyzed. All patients were followed up for a median time of 63 months (range 19−77) through clinical/biochemical/instrumental examinations performed at baseline and after stopping the DAA treatment. At the end of the evaluation, 230 (71%) individuals showed stable clinical liver disease over time, 43 (13.3%) developed HCC, and 24 (7.4%) developed hepatic decompensation without HCC. Overall, 49 (15,1%) patients died. Multivariate regression analysis showed that hepatic decompensation was significantly associated with at baseline older age, higher liver stiffness, higher spleen longitudinal size values and hypergammaglobulinemia (p = 0.003, p = 0.005, p = 0.001, p = 0.029, respectively). HCC development was significantly associated with hypergammaglobulinemia (p < 0.001). Death was associated with older age and hypergammaglobulinemia (p < 0.001 and p = 0.007, respectively). Finally, survival analysis confirmed that patients with gamma globulin levels ≥ 1.8 gr/dl had a significantly higher risk of death compared to those with gamma globulin levels < 1.8 gr/dl (p < 0.001). In conclusion, hypergammaglobulinemia before starting DAA therapy represents a strong predictor of hepatic decompensation, HCC and death in cirrhotic patients even after HCV clearance." @default.
• W4307989369 created "2022-11-07" @default.
• W4307989369 creator A5000317966 @default.
• W4307989369 creator A5003273707 @default.
• W4307989369 creator A5009294046 @default.
• W4307989369 creator A5009721396 @default.
• W4307989369 creator A5037039005 @default.
• W4307989369 creator A5043591327 @default.
• W4307989369 creator A5051168561 @default.
• W4307989369 creator A5057334553 @default.
• W4307989369 creator A5063728960 @default.
• W4307989369 creator A5064787053 @default.
• W4307989369 creator A5070122810 @default.
• W4307989369 date "2022-10-31" @default.
• W4307989369 modified "2023-10-18" @default.
• W4307989369 title "Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV Clearance" @default.
• W4307989369 cites W2111335059 @default.
• W4307989369 cites W2114376411 @default.
• W4307989369 cites W216121951 @default.
• W4307989369 cites W2163403599 @default.
• W4307989369 cites W2185218296 @default.
• W4307989369 cites W2277004004 @default.
• W4307989369 cites W2520869351 @default.
• W4307989369 cites W2522939307 @default.
• W4307989369 cites W2546046192 @default.
• W4307989369 cites W2546694404 @default.
• W4307989369 cites W2605644052 @default.
• W4307989369 cites W2736841222 @default.
• W4307989369 cites W2742937844 @default.
• W4307989369 cites W2751505630 @default.
• W4307989369 cites W2761518106 @default.
• W4307989369 cites W2793276816 @default.
• W4307989369 cites W2797952741 @default.
• W4307989369 cites W2800171985 @default.
• W4307989369 cites W2883468137 @default.
• W4307989369 cites W2898312159 @default.
• W4307989369 cites W2913125611 @default.
• W4307989369 cites W2913385034 @default.
• W4307989369 cites W2946400986 @default.
• W4307989369 cites W3010088470 @default.
• W4307989369 cites W3014283231 @default.
• W4307989369 cites W3041265799 @default.
• W4307989369 cites W3048281202 @default.
• W4307989369 cites W3088020815 @default.
• W4307989369 cites W3107529120 @default.
• W4307989369 cites W3124214328 @default.
• W4307989369 cites W3158779356 @default.
• W4307989369 cites W3202295198 @default.
• W4307989369 cites W4200473175 @default.
• W4307989369 cites W4211051574 @default.
• W4307989369 cites W4283206840 @default.
• W4307989369 cites W4302195001 @default.
• W4307989369 cites W571628560 @default.
• W4307989369 cites W2775656375 @default.
• W4307989369 doi "https://doi.org/10.3390/jpm12111794" @default.
• W4307989369 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36579534" @default.
• W4307989369 hasPublicationYear "2022" @default.
• W4307989369 type Work @default.
• W4307989369 citedByCount "0" @default.
• W4307989369 crossrefType "journal-article" @default.
• W4307989369 hasAuthorship W4307989369A5000317966 @default.
• W4307989369 hasAuthorship W4307989369A5003273707 @default.
• W4307989369 hasAuthorship W4307989369A5009294046 @default.
• W4307989369 hasAuthorship W4307989369A5009721396 @default.
• W4307989369 hasAuthorship W4307989369A5037039005 @default.
• W4307989369 hasAuthorship W4307989369A5043591327 @default.
• W4307989369 hasAuthorship W4307989369A5051168561 @default.
• W4307989369 hasAuthorship W4307989369A5057334553 @default.
• W4307989369 hasAuthorship W4307989369A5063728960 @default.
• W4307989369 hasAuthorship W4307989369A5064787053 @default.
• W4307989369 hasAuthorship W4307989369A5070122810 @default.
• W4307989369 hasBestOaLocation W43079893691 @default.
• W4307989369 hasConcept C126322002 @default.
• W4307989369 hasConcept C159654299 @default.
• W4307989369 hasConcept C203014093 @default.
• W4307989369 hasConcept C2522874641 @default.
• W4307989369 hasConcept C2776408679 @default.
• W4307989369 hasConcept C2776455275 @default.
• W4307989369 hasConcept C2777075537 @default.
• W4307989369 hasConcept C2777214474 @default.
• W4307989369 hasConcept C2778019345 @default.
• W4307989369 hasConcept C2778721985 @default.
• W4307989369 hasConcept C2779134260 @default.
• W4307989369 hasConcept C2780514984 @default.
• W4307989369 hasConcept C71924100 @default.
• W4307989369 hasConcept C79162176 @default.
• W4307989369 hasConcept C90924648 @default.
• W4307989369 hasConceptScore W4307989369C126322002 @default.
• W4307989369 hasConceptScore W4307989369C159654299 @default.
• W4307989369 hasConceptScore W4307989369C203014093 @default.
• W4307989369 hasConceptScore W4307989369C2522874641 @default.
• W4307989369 hasConceptScore W4307989369C2776408679 @default.
• W4307989369 hasConceptScore W4307989369C2776455275 @default.
• W4307989369 hasConceptScore W4307989369C2777075537 @default.
• W4307989369 hasConceptScore W4307989369C2777214474 @default.
• W4307989369 hasConceptScore W4307989369C2778019345 @default.
• W4307989369 hasConceptScore W4307989369C2778721985 @default.
• W4307989369 hasConceptScore W4307989369C2779134260 @default.

• next